179 related articles for article (PubMed ID: 27318474)
1. Glycomics of human embryonic stem cells and human induced pluripotent stem cells.
Furukawa J; Okada K; Shinohara Y
Glycoconj J; 2016 Oct; 33(5):707-15. PubMed ID: 27318474
[TBL] [Abstract][Full Text] [Related]
2. Glycomics of human embryonic stem cells and human induced pluripotent stem cells.
Furukawa JI; Okada K; Shinohara Y
Glycoconj J; 2017 Dec; 34(6):807-815. PubMed ID: 29150735
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in cellular glycomic analyses.
Furukawa J; Fujitani N; Shinohara Y
Biomolecules; 2013 Feb; 3(1):198-225. PubMed ID: 24970165
[TBL] [Abstract][Full Text] [Related]
4. Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.
Fujitani N; Furukawa J; Araki K; Fujioka T; Takegawa Y; Piao J; Nishioka T; Tamura T; Nikaido T; Ito M; Nakamura Y; Shinohara Y
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2105-10. PubMed ID: 23345451
[TBL] [Abstract][Full Text] [Related]
5. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.
Toyoda H; Nagai Y; Kojima A; Kinoshita-Toyoda A
Glycoconj J; 2017 Apr; 34(2):139-145. PubMed ID: 28078490
[TBL] [Abstract][Full Text] [Related]
6. Glycoconjugates reveal diversity of human neural stem cells (hNSCs) derived from human induced pluripotent stem cells (hiPSCs).
Kandasamy M; Roll L; Langenstroth D; Brüstle O; Faissner A
Cell Tissue Res; 2017 Jun; 368(3):531-549. PubMed ID: 28299522
[TBL] [Abstract][Full Text] [Related]
7. Glycolipid dynamics in generation and differentiation of induced pluripotent stem cells.
Ojima T; Shibata E; Saito S; Toyoda M; Nakajima H; Yamazaki-Inoue M; Miyagawa Y; Kiyokawa N; Fujimoto JI; Sato T; Umezawa A
Sci Rep; 2015 Oct; 5():14988. PubMed ID: 26477663
[TBL] [Abstract][Full Text] [Related]
8. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.
Toyoda H; Nagai Y; Kojima A; Kinoshita-Toyoda A
Glycoconj J; 2017 Dec; 34(6):817-823. PubMed ID: 28980094
[TBL] [Abstract][Full Text] [Related]
9. Quantitative glycomics monitoring of induced pluripotent- and embryonic stem cells during neuronal differentiation.
Terashima M; Amano M; Onodera T; Nishimura S; Iwasaki N
Stem Cell Res; 2014 Nov; 13(3 Pt A):454-64. PubMed ID: 25460606
[TBL] [Abstract][Full Text] [Related]
10. The Cell-Surface N-Glycome of Human Embryonic Stem Cells and Differentiated Hepatic Cells thereof.
Montacir H; Freyer N; Knöspel F; Urbaniak T; Dedova T; Berger M; Damm G; Tauber R; Zeilinger K; Blanchard V
Chembiochem; 2017 Jul; 18(13):1234-1241. PubMed ID: 28370937
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells.
Säljö K; Barone A; Vizlin-Hodzic D; Johansson BR; Breimer ME; Funa K; Teneberg S
Glycobiology; 2017 Apr; 27(4):291-305. PubMed ID: 27932383
[TBL] [Abstract][Full Text] [Related]
12. "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".
Cummings RD
Glycoconj J; 2019 Aug; 36(4):241-257. PubMed ID: 31267247
[TBL] [Abstract][Full Text] [Related]
13. Integrative omics connects N-glycoproteome-wide alterations with pathways and regulatory events in induced pluripotent stem cells.
Sudhir PR; Kumari MP; Hsu WT; Chen CH; Kuo HC; Chen CH
Sci Rep; 2016 Nov; 6():36109. PubMed ID: 27808266
[TBL] [Abstract][Full Text] [Related]
14. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199.
García CP; Videla Richardson GA; Dimopoulos NA; Fernandez Espinosa DD; Miriuka SG; Sevlever GE; Romorini L; Scassa ME
PLoS One; 2016; 11(3):e0152607. PubMed ID: 27030982
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the early response of human embryonic stem cells and human induced pluripotent stem cells to ionizing radiation.
Suchorska WM; Augustyniak E; Łukjanow M
Mol Med Rep; 2017 Apr; 15(4):1952-1962. PubMed ID: 28259963
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Residual Human-Induced Pluripotent Stem Cells in Human Chondrocytes by Cell Type-Specific Glycosphingolipid Glycome Analysis Based on the Aminolysis-SALSA Technique.
Miyazaki T; Hanamatsu H; Xu L; Onodera T; Furukawa JI; Homan K; Baba R; Kawasaki T; Iwasaki N
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905707
[TBL] [Abstract][Full Text] [Related]
17. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
18. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Assessment of Sialo-Glycoproteins and N-Glycans during Cardiomyogenic Differentiation of Human Induced Pluripotent Stem Cells.
Konze SA; Cajic S; Oberbeck A; Hennig R; Pich A; Rapp E; Buettner FFR
Chembiochem; 2017 Jul; 18(13):1317-1331. PubMed ID: 28509371
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Glycomic Approach Reveals Novel Low-Molecular-Weight Blood Group-Specific Glycans in Serum and Cerebrospinal Fluid.
Furukawa JI; Hanamatsu H; Yokota I; Hirayama M; Ando T; Kobayashi H; Ohnishi S; Miura N; Okada K; Sakai S; Yuyama K; Igarashi Y; Ito M; Shinohara Y; Sakamoto N
J Proteome Res; 2021 May; 20(5):2812-2822. PubMed ID: 33719461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
